Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Search by expertise, name or affiliation
Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management
S. Monjazeb,
J. Wilson
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cutaneous Adverse Drug Reactions (cADRs)
100%
Epidermal Growth Factor Receptor Inhibitors
100%
Adverse Effects
33%
Epithelial Tissue
33%
Patient Well-being
33%
Response to Therapy
33%
Targeted Therapy
33%
Hair Follicle
33%
Skin Follicles
33%
Epidermal Growth Factor Receptor
33%
Target Pathways
33%
Anticancer Medicines
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Side Effect
100%
Epidermal Growth Factor Receptor Kinase Inhibitor
100%
Epidermal Growth Factor Receptor
50%